|  Help  |  About  |  Contact Us

Publication : Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-κB signaling pathway.

First Author  Dong X Year  2023
Journal  J Neuroinflammation Volume  20
Issue  1 Pages  146
PubMed ID  37349834 Mgi Jnum  J:348212
Mgi Id  MGI:7492826 Doi  10.1186/s12974-023-02824-8
Citation  Dong X, et al. (2023) Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-kappaB signaling pathway. J Neuroinflammation 20(1):146
abstractText  Previous studies have shown that Ogt-mediated O-GlcNAcylation is essential for neuronal development and function. However, the function of O-GlcNAc transferase (Ogt) and O-GlcNAcylation in astrocytes remains largely unknown. Here we show that Ogt deficiency induces inflammatory activation of astrocytes in vivo and in vitro, and impairs cognitive function of mice. The restoration of O-GlcNAcylation via GlcNAc supplementation inhibits the activation of astrocytes, inflammation and improves the impaired cognitive function of Ogt deficient mice. Mechanistically, Ogt interacts with NF-kappaB p65 and catalyzes the O-GlcNAcylation of NF-kappaB p65 in astrocytes. Ogt deficiency induces the activation of NF-kappaB signaling pathway by promoting Gsk3beta binding. Moreover, Ogt depletion induces the activation of astrocytes derived from human induced pluripotent stem cells. The restoration of O-GlcNAcylation inhibits the activation of astrocytes, inflammation and reduces Abeta plaque of AD mice in vitro and in vivo. Collectively, our study reveals a critical function of Ogt-mediated O-GlcNAcylation in astrocytes through regulating NF-kappaB signaling pathway.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

15 Bio Entities

Trail: Publication

0 Expression